NORMAPHAR
ActiveSummary
The computed 12-month bankruptcy probability of NORMAPHAR is 9.5% (elevated). For NORMAPHAR, at least two filing cycles of the annual accounts are missing. The 2023 annual accounts show negative equity (-€61,995) and a net result of -€101,665. The figures fluctuate too strongly year-on-year for a reliable trend projection. The company has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals.
Group and network
Holdings and subsidiaries
1 holdingHoldings 1
- NORMAPHAR France SasuFRsubsidiarySourceown accounts 2023100%
According to the 2023 annual accounts of NORMAPHAR and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
The network starts from this company’s shareholders. What else they own or run appears here as nodes.